These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21418662)

  • 1. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.
    Molderings GJ; Brettner S; Homann J; Afrin LB
    J Hematol Oncol; 2011 Mar; 4():10. PubMed ID: 21418662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options in the treatment of mast cell mediator-related symptoms in mastocytosis.
    Escribano L; Akin C; Castells M; Schwartz LB
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):61-77. PubMed ID: 16613565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease.
    Wirz S; Molderings GJ
    Pain Physician; 2017 Sep; 20(6):E849-E861. PubMed ID: 28934791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell activation disorders.
    Akin C
    J Allergy Clin Immunol Pract; 2014; 2(3):252-7.e1; quiz 258. PubMed ID: 24811013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular symptoms in patients with systemic mast cell activation disease.
    Kolck UW; Haenisch B; Molderings GJ
    Transl Res; 2016 Aug; 174():23-32.e1. PubMed ID: 26775802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.
    Afrin LB; Dempsey TT; Rosenthal LS; Dorff SR
    J Obstet Gynaecol; 2019 Jul; 39(5):664-669. PubMed ID: 30964355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment options for mast cell activation disease.
    Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mast cell activation syndrome].
    Brockow K
    Hautarzt; 2013 Feb; 64(2):102-6. PubMed ID: 23385621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell activation syndromes.
    Lee MJ; Akin C
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):5-8. PubMed ID: 23806452
    [No Abstract]   [Full Text] [Related]  

  • 10. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell disorders: Protean manifestations and treatment responses.
    Chen M; Kim A; Zuraw B; Doherty TA; Christiansen S
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):128-130. PubMed ID: 29604336
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment strategies in mastocytosis.
    Siebenhaar F; Akin C; Bindslev-Jensen C; Maurer M; Broesby-Olsen S
    Immunol Allergy Clin North Am; 2014 May; 34(2):433-47. PubMed ID: 24745685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic mastocytosis--definition of an internal disease].
    Homann J; Kolck UW; Ehnes A; Frieling T; Raithel M; Molderings GJ
    Med Klin (Munich); 2010 Aug; 105(8):544-53. PubMed ID: 20824412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
    Molderings GJ; Homann J; Brettner S; Raithel M; Frieling T
    Dtsch Med Wochenschr; 2014 Jul; 139(30):1523-34; quiz 1535-8. PubMed ID: 24801454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mastocytosis in children. Report of 3 cases].
    Gazca Aguilar A; Frías Castro LO; Balbuena Rosas EJ; Ontiveros Nevares P; Mena Cedillos CA
    Rev Alerg Mex; 1996; 43(4):84-9. PubMed ID: 8983646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report of mastocytosis in an adult.
    Barker A; Stewart RW
    South Med J; 2009 Jan; 102(1):91-3. PubMed ID: 19077784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastocytosis: advances in diagnosis and treatment.
    Hungness SI; Akin C
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):248-54. PubMed ID: 17547845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cell Disorders In Drug Hypersensitivity.
    Bonadonna P; Bonifacio M; Zanotti R
    Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis: current concepts in diagnosis and treatment.
    Escribano L; Akin C; Castells M; Orfao A; Metcalfe DD
    Ann Hematol; 2002 Dec; 81(12):677-90. PubMed ID: 12483363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.